Fibrolamellar hepatocellular carcinoma

Reporting session

Published in Deepak Subedi, Marialena Gregoriades, En Hsun Choi, John T Murchison, Graham McKillop, A Complete Guide to the Final FRCR 2B, 2011

Deepak Subedi, Marialena Gregoriades, En Hsun Choi, John T Murchison, Graham McKillop

Fibrolamellar hepatocellular carcinoma. However, this is less likely as the scar in FNH is generally low signal on both T1 and T2, enhancement is heterogeneous in both the arterial and portovenous phase, and the central scar does not usually enhance.

Pediatric fibrolamellar hepatocellular carcinoma: case report and review of the literature

View Article

Journal Information

Published in Acta Chirurgica Belgica, 2021

Laura Depauw, Glenn De Weerdt, Ben Gys, Sofie Demeulenaere, Wouter Mebis, Dirk Ysebaert

Further workup of the case was carried out via magnetic resonance imaging (MRI) which confirmed a subcapsular lesion (5.7 × 4.6 × 4.1 cm) at the transition of liver segments 5, 6 and 8 with signs of recent bleeding (Figure 1). The MRI characteristics were compatible with that of a primary liver lesion in an otherwise healthy liver, suggestive for a fibrolamellar hepatocellular carcinoma (FL-HCC). Positron emission tomography (PET)—computed tomography (CT) confirmed the presence of the liver lesion with a mild to moderate fluorodeoxyglucose (FDG) avidity. No other FDG avid lesions were detected, not intra- nor extrahepatic. Tumor markers (alpha-fetoprotein, carcinoembryonic antigen and beta-human chorionic gonadotropin) were negative.

Fibrolamellar hepatocellular carcinoma

Explore chapters and articles related to this topic

Reporting session

Pediatric fibrolamellar hepatocellular carcinoma: case report and review of the literature